SangKon Oh

1.6k citations
14 papers · 1.3k indexed · 1 hit paper · h-index 12

SangKon Oh

14 papers receiving 1.3k citations

Hit Papers

Synergy of IL-21 and IL-15 in regulating CD8+ T cell expa...5922005202620122019100200300400500

Peers

SangKon Oh
Comparison fields: 5 of 72
  • Immunology 1.1k
  • Oncology 411
  • Virology 60
  • Microbiology 36
  • Biotechnology 42
Replace SangKon Oh with:
SangKon Oh United States
Bruno Salaun Belgium
Shabnam Tangri United States
Roberto De Pascalis United States
Eynav Klechevsky United States
Rebecca Merica United States
Marika Pla France
Sophie Sierro United Kingdom
Daniel Benítez‐Ribas Spain
Maggi Pack United States
SangKon Oh relative to SangKon Oh United States SangKon Oh's profile →
Citations per field
00.5×1.5×1.8×
SangKon Oh · 1×
Citations per year

Countries citing papers authored by SangKon Oh

Since Specialization
Citations

This map shows the geographic impact of SangKon Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SangKon Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SangKon Oh more than expected).

Fields of papers citing papers by SangKon Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SangKon Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SangKon Oh. The network helps show where SangKon Oh may publish in the future.

Co-authorship network

The 25 scholars most cited alongside SangKon Oh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with SangKon Oh Line = papers co-authored together SangKon Oh links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 202113
2 201810
3 20157
4 201423
5 201418
6 2012141
7 201226
8 201235
9 201268
10
Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and functionbreakdown →
2005592
11 2004187
12 200458
13 2003102
14 200115

About SangKon Oh

SangKon Oh is a scholar working on Immunology, Endocrinology and Immunology and Allergy, having authored 14 papers that have together received 1.3k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers), Immune Response and Inflammation (3 papers), vaccines and immunoinformatics approaches (2 papers), Asthma and respiratory diseases (2 papers), Reproductive System and Pregnancy (2 papers) and Influenza Virus Research Studies (1 paper). The work is most often cited by research in Immunology (1.1k citations), Oncology (411 citations) and Virology (60 citations). SangKon Oh has collaborated with scholars based in United States, France and Spain. Frequent co-authors include Jay A. Berzofsky, Christian S. Hinrichs, Nicholas P. Restifo, Michael F. Radonovich, Warren J. Leonard, Steven E. Finkelstein, Panu E. Kovanen, Rosanne Spolski, Cynthia A. Pise-Masison and Rong Zeng. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026